The inhibition of PC cell growth by API may be due to the downregulation of PI3K/AKT and MAPK/MEK/ERK pathways as these kinases are down stream of Kras oncogene which is mutated in 90% of patients with PC [79,80]. The gene discussed is AKT1; the disease is pachyonychia congenita.